ChoiceSpine launched a biologics portfolio, adding allograft, synthetic bone graft and amnion offerings to complement its spinal hardware. STRATOFUSE™ comprises demineralized bone allograft putties and sponges, synthetic bone graft substitute putties and strips, structural allograft and allograft bone extenders. STRATOGEN™ includes a full amnion offering.
The addition of the biologics line follows ChoiceSpine’s 1Q17 acquisition of Exactech’s spine products, which encompass cervical, thoracolumbar and interbody implants and minimally invasive instrument systems.
Sources: ChoiceSpine; ORTHOWORLD Inc.
ChoiceSpine launched a biologics portfolio, adding allograft, synthetic bone graft and amnion offerings to complement its spinal hardware. STRATOFUSE™ comprises demineralized bone allograft putties and sponges, synthetic bone graft substitute putties and strips, structural allograft and allograft bone extenders. STRATOGEN™ includes a full amnion...
ChoiceSpine launched a biologics portfolio, adding allograft, synthetic bone graft and amnion offerings to complement its spinal hardware. STRATOFUSE™ comprises demineralized bone allograft putties and sponges, synthetic bone graft substitute putties and strips, structural allograft and allograft bone extenders. STRATOGEN™ includes a full amnion offering.
The addition of the biologics line follows ChoiceSpine’s 1Q17 acquisition of Exactech’s spine products, which encompass cervical, thoracolumbar and interbody implants and minimally invasive instrument systems.
Sources: ChoiceSpine; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.